The most valuable marijuana company in the U.S. is under fire for how it’s marketing and selling CBD, the trendy cannabis extract now sold at national retailers. The Food and Drug Administration sent Curaleaf Holdings Inc. President Joseph Lusardi a …
Source: Claims Journal